Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 5/20 | 0.49 |
| ▸ | DBF4 | Q9UBU7 | 5/20 | 0.49 |
| ▸ | SREBF2 | Q12772 | 5/20 | 0.41 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | WNT3A | P56704 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.33 |
| ▸ | CCNC | P24863 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4170788 | 0.76 | ALDH1A1 (0.63) | CDC7DBF4SREBF2SREBF1PDE10A | |
| SCHEMBL4154288 | 0.76 | HSD17B10 (0.43) | ALDH1A1RAB9AKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL2412008 | 0.75 | CYP1A2 (0.54) | ALDH1A1RAB9AKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL27875453 | 0.74 | CDC7 (0.63) | CDC7DBF4SREBF2SREBF1ALDH1A1 | |
| SCHEMBL4164806 | 0.72 | KDM4E (0.36) | ALDH1A1RAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL28628291 | 0.71 | CDC7 (0.80) | CDC7DBF4ALDH1A1MAPTLMNA | |
| SCHEMBL4161913 | 0.71 | CCNC (0.36) | ALDH1A1RAB9AKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL4167341 | 0.70 | KDM4E (0.53) | ALDH1A1RAB9AKMT2ASMN1; SMN2NPC1 | |
| SCHEMBL5164107 | 0.70 | CDC7 (0.52) | CDC7DBF4SREBF2SREBF1PDE10A | |
| SCHEMBL6496072 | 0.69 | CDC7 (0.57) | CDC7DBF4SREBF2SREBF1PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137572-A1 | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | CYCLACEL LIMITED (GB) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137572-A1 | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | CDK2, CDK4, CDK20 | CDC7 206/4885DBF4 2211/4885SREBF2 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.